Dr. Wu Skincare Co., Ltd. (TPEX: 6523)

Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	189.97	474.88	651.55	1,029	712.36	627.03
Short-Term Investments	704	781.47	696.8	366.3	871.2	977.98
Trading Asset Securities	19.46	18.66	17.77	19.65	20.71	23.32
Cash & Short-Term Investments	913.43	1,275	1,366	1,415	1,604	1,628
Cash Growth	-29.42%	-6.67%	-3.43%	-11.82%	-1.48%	10.27%
Accounts Receivable	142.17	138.92	130.52	149.05	102.34	182.48
Other Receivables	3.32	2.8	1.84	2.06	306.62	6.71
Receivables	145.49	141.71	132.36	151.11	408.97	189.19
Inventory	224.29	188.76	115.2	115.18	103.02	102.23
Prepaid Expenses	8.21	16.43	3.84	7.84	8.44	7.51
Other Current Assets	399.6	2.78	2.04	2.13	0.3	2.9
Total Current Assets	1,691	1,625	1,620	1,691	2,125	1,930
Property, Plant & Equipment	31.92	7.65	14.54	22.51	28.82	39.07
Long-Term Investments	272.27	119.7	134.74	93.33	77.48	48.41
Other Intangible Assets	0.69	0.79	0.05	0.25	2.91	4.74
Long-Term Accounts Receivable	19.45	-	1.99	6.68	11.25	-
Long-Term Deferred Tax Assets	7.9	7.77	6.71	10.07	8.76	4.74
Other Long-Term Assets	4.81	4.83	5.63	7.33	10.74	25.42
Total Assets	2,028	1,765	1,783	1,831	2,265	2,053
Accounts Payable	94.22	62.69	46.71	89.95	28.52	42.22
Accrued Expenses	57.19	90.73	80.1	95.23	51	48.13
Current Portion of Leases	9.66	5.05	10.08	9.83	9.39	9.15
Current Income Taxes Payable	70.65	80.35	40.51	40.15	121.39	2.32
Current Unearned Revenue	11.91	8.26	8.05	13.59	12.44	8.81
Other Current Liabilities	205.45	41.8	33.75	30.42	17.56	22.68
Total Current Liabilities	449.07	288.88	219.18	279.16	240.3	133.3
Long-Term Leases	41.9	-	5.6	15.68	24.59	33.98
Long-Term Deferred Tax Liabilities	2.91	0.98	28.18	-	-	0
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.49	1.49
Total Liabilities	495.14	291.12	254.22	296.1	266.37	168.77
Common Stock	450.48	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	331.89	331.89	421.99	512.08	692.27	1,143
Retained Earnings	750.56	691.96	548.78	479.09	778.38	291.15
Comprensive Income & Other	-	-	107.77	93.31	77.45	-0.61
Total Common Equity	1,533	1,474	1,529	1,535	1,999	1,884
Shareholders' Equity	1,533	1,474	1,529	1,535	1,999	1,884
Total Liabilities & Equity	2,028	1,765	1,783	1,831	2,265	2,053
Total Debt	51.56	5.05	15.68	25.5	33.98	43.13
Net Cash (Debt)	861.87	1,270	1,350	1,389	1,570	1,585
Net Cash Growth	-32.89%	-5.96%	-2.78%	-11.54%	-0.94%	7.35%
Net Cash Per Share	19.11	28.17	29.95	30.80	34.76	35.17
Filing Date Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Working Capital	1,242	1,336	1,400	1,412	1,885	1,797
Book Value Per Share	34.03	32.73	33.94	34.07	44.37	41.82
Tangible Book Value	1,532	1,474	1,529	1,535	1,996	1,879
Tangible Book Value Per Share	34.01	32.71	33.94	34.07	44.30	41.71
Machinery	-	-	-	-	1	1.27
Leasehold Improvements	-	-	-	-	20.64	34.82

Source: S&P Capital IQ. Standard template. Financial Sources.